For the Inventor, By the Inventor

Enter assignee name

Rotterdam, Netherlands

Gamida for Life B.v.

USPTO Granted Patents = 16

% Expired Patents = 87.5

EPO Patents = 1

Forward Citations = 46

Loading Chart...

Loading Chart...

47 inventors (with patents filed for the assignee):

Michael James Heller (7 out of 47 patents)

Eugene Tu (4 out of 64 patents)

Ronald George Sosnowski (3 out of 16 patents)

4. Carl Frederick Edman (2 out of 23 patents)

5. Paul David Swanson (2 out of 72 patents)

6. Phillip Schardt (2 out of 2 patents)

7. Chris Langley (2 out of 2 patents)

8. James P O'Connell (2 out of 17 patents)

9. James Light (2 out of 2 patents)

10. Jing Cheng (1 out of 96 patents)

11. James P Light, Ii (1 out of 30 patents)

12. Howard Reese (1 out of 9 patents)

13. Donald E Ackley (1 out of 68 patents)

14. Lei Wu (1 out of 31 patents)

15. Ray R Radtkey (1 out of 5 patents)

16 patents: Sort by Forward Citations

1. 8772467 - Methods and apparatus for screening and detecting multiple genetic mutations (2014-07-08),

2. 8630807 - Methods for the electronic, homogeneous assembly and fabrication of devices (2014-01-14),

3. 8549904 - Fluidic volume dispense verification tool (2013-10-08),

4. 8389212 - Method for the electronic analysis of a sample oligonucleotide sequence (2013-03-05),

5. 8313940 - Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics (2012-11-20),

6. 8288155 - Biomolecular attachment sites on microelectronic arrays and methods thereof (2012-10-16),

7. 8114589 - Self-addressable self-assembling microelectronic integrated systems, component devices, mechanisms, methods, and procedures for molecular biological analysis and diagnostics (2012-02-14),

8. 7947486 - Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics (2011-05-24),

9. 7943023 - Programmable multiplexed active biologic array (2011-05-17),

10. 7861581 - Fluidic volume dispense verification tool (2011-01-04),

11. 7858034 - Circuits for the control of output current in an electronic device for performing active biological operations (2010-12-28),

12. 7857957 - Integrated portable biological detection system (2010-12-28),

13. 7828954 - Electrode based patterning of thin film self-assembled nanoparticles (2010-11-09),

14. 7704726 - Active programmable matrix devices (2010-04-27),

15. 7687103 - Compositions and methods for preserving permeation layers for use on active electronic matrix devices (2010-03-30),

Company Overview

Gamida for Life B.V., based in Rotterdam, specializes in innovative cell therapy solutions aimed at improving patient outcomes in the field of hematology and oncology. The company focuses on developing advanced technologies for the expansion and enhancement of hematopoietic stem cells, which are crucial for treating various blood disorders. With a commitment to research and development, Gamida for Life is dedicated to transforming the landscape of regenerative medicine and providing new therapeutic options for patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

16 Patents

#10 in Rotterdam

#431 in Netherlands

#37,831 in the World

Rotterdam, Netherlands

Gamida for Life B.v.

Forward Citations = 46

47 inventors:

Michael James Heller (7 out of 47 patents)

Eugene Tu (4 out of 64 patents)

Ronald George Sosnowski (3 out of 16 patents)

4. Carl Frederick Edman (2 out of 23 patents)

5. Paul David Swanson (2 out of 72 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gamida for Life B.v.. Retrieved from https://idiyas.com/company/gamida-for-life-b-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…